We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




International Nanomedicine Society

By Biotechdaily staff writers
Posted on 15 Jun 2005
The American Academy of Nanomedicine (Washington, DC, USA), an international society created to advance clinical applications and research in the field of nanomedicine, has announced its launch.

The academy is a professional membership organization representing basic and clinical investigators, engineers, molecular biologists, physicians, and others with an interest in the field, and is the only society devoted specifically to the emerging field of nanomedicine. More...
The academy will offer a venue to exchange ideas, communicate new findings, and encourage collaboration among the diverse fields represented in nanomedicine.

Nanomedicine, an extension of nanotechnology, refers to highly specific medical intervention at the molecular level for curing disease or repairing injured tissues, such as nerve, bone, or muscle. A nanometer is one-billionth of a meter, too small to be seen with a traditional laboratory microscope. Nanomedicine uses molecular machine systems to tackle medical problems, and uses molecular knowledge to maintain and improve human health at the molecular level. Nanomedicine has remarkable and far-reaching implications for the medical profession, for the definition of disease, for the diagnosis and treatment of medical conditions including aging, and for the improvement and extension of natural human biological structure and function.

"We are breaking new ground,” said Dr. Chiming Wei, director of the Cardiothoracic-Renal Molecular Research Program at Baltimore's Johns Hopkins University, School of Medicine (Baltimore, MD, USA), who leads the steering committee organizing the launch effort. "The academy will provide a link between the academic research communities in the field of nanomedicine and help foster better communication in the field.”

"We are proud to be bringing together the leading minds in the emerging field of nanomedicine and are very excited by the enormous scientific developments in this area, as well as the interest in the Academy's upcoming First Annual Meeting,” said Karen Hasson, the executive director of the academy.

The academy will hold its first annual meeting at Johns Hopkins University (Baltimore, MD, USA), August 15-16, 2005.




Related Links:
American Academy of Nanomedicine

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Clinical Informatics Platform
CLARION™
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.